ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,350.93
1.57%
US Tech 100
18,118.00
1.52%
다우존스 지수
40,170.95
1.46%
Bitcoin
83,837.77
5.29%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Taysha Gene Therapies Inc (TSHA) 시세

Taysha Gene Therapies Inc

Taysha Gene Therapies Inc (TSHA)

NASDAQ
1.235
0.065
( 5.56% )
업데이트: 03:23:22
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
1.235
매수가
1.23
매도가
1.24
거래량
502,828
1.14 일간 변동폭 1.25
1.05 52주 범위 4.32
market_cap
253.177M
전일 종가
1.17
개장가
1.16
최근 거래 시간
6
@
1.2311
마지막 거래 시간
03:24:18
재정 규모
US$ 600,289
VWAP
1.1938
평균 볼륨(3m)
2,122,837
발행 주식
205,001,632
배당수익률
-
주가수익률
-2.71
주당순이익(EPS)
-0.44
매출
8.33M
순이익
-89.3M

Taysha Gene Therapies Inc 정보

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and com... Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. It is advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs. Its product candidates include TSHA-101, TSHA-118, TSHA-102, TSHA-103, and TSHA-104. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.tayshagtx.com
본부
Dover, Delaware, USA
설립됨
-
Taysha Gene Therapies Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker TSHA. The last closing price for Taysha Gene Therapies was US$1.17. Over the last year, Taysha Gene Therapies shares have traded in a share price range of US$ 1.05 to US$ 4.32.

Taysha Gene Therapies currently has 205,001,632 shares in issue. The market capitalisation of Taysha Gene Therapies is US$239.85 million. Taysha Gene Therapies has a price to earnings ratio (PE ratio) of -2.71.

TSHA 최신 뉴스

추가 뉴스

Form PRE 14A - Other preliminary proxy statements
Edgar (US Regulatory)
23 시간 전
TSHA (5.56%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
26 2월 2025
TSHA (5.56%)

Form 8-K - Current report
Edgar (US Regulatory)
26 2월 2025
TSHA (5.56%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
06 2월 2025
TSHA (5.56%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
08 1월 2025
TSHA (5.56%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.0252.066115702481.211.291.0517888861.19610109CS
4-0.495-28.6127167631.731.951.0526309031.4851502CS
12-0.365-22.81251.61.951.0521228371.56152291CS
26-0.745-37.62626262631.983.311.0533425051.95495019CS
52-1.995-61.76470588243.234.321.0526077572.19050029CS
156-4.595-78.81646655235.836.110.520296752.26150116CS
260-21.015-94.449438202222.2533.840.513927232.85887793CS

TSHA - Frequently Asked Questions (FAQ)

What is the current Taysha Gene Therapies share price?
The current share price of Taysha Gene Therapies is US$ 1.235
How many Taysha Gene Therapies shares are in issue?
Taysha Gene Therapies has 205,001,632 shares in issue
What is the market cap of Taysha Gene Therapies?
The market capitalisation of Taysha Gene Therapies is USD 239.85M
What is the 1 year trading range for Taysha Gene Therapies share price?
Taysha Gene Therapies has traded in the range of US$ 1.05 to US$ 4.32 during the past year
What is the PE ratio of Taysha Gene Therapies?
The price to earnings ratio of Taysha Gene Therapies is -2.71
What is the cash to sales ratio of Taysha Gene Therapies?
The cash to sales ratio of Taysha Gene Therapies is 29.06
What is the reporting currency for Taysha Gene Therapies?
Taysha Gene Therapies reports financial results in USD
What is the latest annual turnover for Taysha Gene Therapies?
The latest annual turnover of Taysha Gene Therapies is USD 8.33M
What is the latest annual profit for Taysha Gene Therapies?
The latest annual profit of Taysha Gene Therapies is USD -89.3M
What is the registered address of Taysha Gene Therapies?
The registered address for Taysha Gene Therapies is 108 LAKELAND AVE, DOVER, DELAWARE, 19901
What is the Taysha Gene Therapies website address?
The website address for Taysha Gene Therapies is www.tayshagtx.com
Which industry sector does Taysha Gene Therapies operate in?
Taysha Gene Therapies operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MSPRMSP Recovery Inc
US$ 2.40
(87.50%)
82.06M
PRTGPortage Biotech Inc
US$ 8.8461
(73.45%)
28.19M
THTXTheratechnologies Inc
US$ 2.0007
(50.43%)
40.49M
BFRGBullfrog AI Holdings Inc
US$ 2.1108
(49.70%)
6.51M
STSSSharps Technology Inc
US$ 0.0263
(43.72%)
521.51M
TOROVToro Corporation
US$ 1.14
(-86.03%)
44.46k
LUCYInnovative Eyewear Inc
US$ 2.32
(-53.13%)
1.73M
XHGXChange TED Inc
US$ 0.1911
(-47.73%)
7.16M
MULNMullen Automotive Inc
US$ 2.1911
(-39.14%)
3.85M
FLDFold Holdings Inc
US$ 2.72
(-32.00%)
1.11M
DMNDamon Inc
US$ 0.0033
(-21.43%)
818.09M
BONBon Natural Life Ltd
US$ 0.0697
(14.83%)
627.18M
STSSSharps Technology Inc
US$ 0.0263
(43.72%)
521.51M
LGMKLogicMark Inc
US$ 0.01
(6.38%)
235.08M
NVDANVIDIA Corporation
US$ 110.74
(2.95%)
218.74M

TSHA Discussion

게시물 보기
georgie18 georgie18 3 월 전
TSHA...$1.53... 🥳... https://finviz.com/insidertrading.ashx?oc=1494695&tc=7 ...Bullish Harami Cross Reversal Pattern...
👍️0
glenn1919 glenn1919 4 월 전
tsha..........................https://stockcharts.com/h-sc/ui?s=tsha&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 4 월 전
TSHA, under $2

👍️0
glenn1919 glenn1919 4 월 전
TSHA.....................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 5 월 전
TSHA..............https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 5 월 전
TSHA...$2.58...Off the $2.10 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 85

Tuesday, November 12, 2024 3:56:56 PM

Post#
89
of 90
TSHA...$2.41...🥳...on the $2.10 gapper alert...All out for now...will revisit...

georgie18

Member Level
Re: None

Monday, November 11, 2024 5:18:23 PM

Post#
664504
of 664675
TSHA...$2.10... https://schrts.co/KsMDABsM ...Psar flipped Bullish...🥳Should be a gapper in the morning...
👍️0
glenn1919 glenn1919 5 월 전
TSHA............................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 5 월 전
TSHA...$2.41...🥳...on the $2.10 gapper alert...All out for now...will revisit...

georgie18

Member Level
Re: None

Monday, November 11, 2024 5:18:23 PM

Post#
664504
of 664675
TSHA...$2.10... https://schrts.co/KsMDABsM ...Psar flipped Bullish...🥳Should be a gapper in the morning...
👍️0
zendeli1 zendeli1 5 월 전
restart soon
👍️0
glenn1919 glenn1919 5 월 전
TSHA....................................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 5 월 전
TSHA.................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 5 월 전
TSHA...$2.10... https://schrts.co/KsMDABsM ...Psar flipped Bullish...🥳Should be a gapper in the morning...
👍️0
nsomniyak nsomniyak 5 월 전
I sent an email to TSHA IR on 11/5 asking if they could explain the sharp drop (at that time) and high volume in the stock. I did not receive an answer.
👍️0
nsomniyak nsomniyak 5 월 전
Premiums were high all last week and today on TSHA call options. Volume in the common has been high as well.
👍️0
Pip611 Pip611 5 월 전
I was thinking the same thing, it started to pop in the afternoon and now it took off after hours
👍️0
nsomniyak nsomniyak 5 월 전
What is going on with TSHA in the AH today? Up sharply - now 2.10
👍️0
Monksdream Monksdream 6 월 전
TSHA under $3
👍️0
Monksdream Monksdream 8 월 전
TSHA under $3
👍️0
TechandBio TechandBio 9 월 전
Started buying shares last year at .77 Riding the houses money now and sold three quarters of my shares at $4.00 range when I saw the double top formation come into play I can see this going to $8.00-$10.00 only on a buyout in the next year. Risky with only a handful of patients dosed and the competition for Rhett but a cunning bet with the management at TSHA. now.
CEO and CMO are best in class. Not a core position but glad I'm in with a few. I hope they have a remedy for these poor kids with Rhett.

$TSHA
👍️0
nsomniyak nsomniyak 9 월 전
If these are senior people in prominent management or technical roles it is pretty standard for them to be granted options as part of their compensation package. They vest over 4 years, so it is not an outright giveaway.

Additionally, since these are NEW employees, by definition they have not manipulated the stock down to get a lower option strike price.

I am fine with this very normal comp package.
👍️ 1
ErnieBilco ErnieBilco 9 월 전
I'm sorry but granting options to NEW employees is absurd - they shouldn't be entitled to stock options UNTIL their one year on the job.

No wonder why this has trouble making gains for shareholders whom the employees actually work for.
👍️0
LegendaryNomad22 LegendaryNomad22 10 월 전
Weird. Both TSHA and NGNE have gene therapy candidates for Rett and both of them tanked today, despite sharing strong interim results. There's an International Rett Syndrome Foundation meeting today and tomorrow, so I wonder if something happened there to take the wind out of the gene therapy treatment class. Anyone have any knowledge here?
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
Diluted on news
👍️0
Pip611 Pip611 10 월 전
Ouch - what happen?
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
TSHA...GAPPING
👍️0
Tiger Money Tiger Money 10 월 전
Yes, no sorry, didn’t mean to imply that. I was asking if you have other bio names you have on your radar (obviously know about this and Huma). Thanks
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
chart has nothing to do with what sector!!
👍️0
Tiger Money Tiger Money 10 월 전
You have the bios nailed down! Any I should put on my radar? As always, thank you as I sincerely appreciate your help and knowledge. Thanks!
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
TSHA BREAK OUT
👍️0
Monksdream Monksdream 10 월 전
TSHA new 52 week high
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
TSHA...HERES 4 DOLLA
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
TSHA...READY FOR 4
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
TSHA...BIO BEAST BREAKING HEWRE CHAINS
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
TSHA HERE WE GO ON THE BREAK OUT!!
👍️0
glenn1919 glenn1919 10 월 전
TSHA......................................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
TSHA HERE COMES THE BREAK
👍️0
TrendTrade2016 TrendTrade2016 10 월 전
TSHA...NEXT BIO READY TO BEAST!
👍️0
FooBarAndGrill FooBarAndGrill 11 월 전
Taysha may have the real ONE-SHOT genetic cure. It may REALLY work.
Good luck getting any health insurance plan to list this $Million dollar shot in their drug formulary.
👍️0
Monksdream Monksdream 11 월 전
TSHA under $5
👍️0
glenn1919 glenn1919 1 년 전
TSHA..............................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
TSHA..READY TO PUSH TO 4.00
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
TSHA...MONSTER
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
TSHA...HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
TSHA..here we go
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
TSHA...MONSTER
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
TSHA NEXT BIO BEAST TO RUN TO 3.61 WATCH THE MAGIC
👍️0
FooBarAndGrill FooBarAndGrill 1 년 전
“Dosing the first pediatric patient with Rett syndrome marks an important step forward in our efforts to broaden the clinical evaluation of TSHA-102 to younger patients with earlier stages of Rett syndrome. We are pleased with our progress on expanding the study of TSHA-102 across a broad population of ages and stages of Rett syndrome to bring a potentially transformative treatment option to all patients and families suffering from this devastating disease,” said Sukumar Nagendran, M.D., President, and Head of R&D of Taysha. “The pediatric trial will build on our ongoing REVEAL adolescent and adult trial, where early data demonstrated improvements across multiple clinical domains in adult patients with the most advanced stage of disease. We also plan to expand our U.S. pediatric trial into the U.K. following the recent acceptance of our CTA by the MHRA.”
👍️0
FooBarAndGrill FooBarAndGrill 1 년 전
Estimated Enrollment : 18 participants
(was 12).
https://classic.clinicaltrials.gov/ct2/show/NCT05606614
👍️0
FooBarAndGrill FooBarAndGrill 1 년 전
“Following review of the initial clinical data from the first two adult patients treated with TSHA-102 and Chemistry, Manufacturing, and Controls (CMC) data, Health Canada has authorized our protocol amendment to include adolescent patients aged 12 years and older in the ongoing REVEAL Phase 1/2 adult trial,”
https://ih.advfn.com/stock-market/NASDAQ/taysha-gene-therapies-TSHA/stock-news/92678004/taysha-gene-therapies-announces-expanded-eligibili
👍️0
FooBarAndGrill FooBarAndGrill 1 년 전
The P1 TSHA-102 REVEAL Adult Study has been on a slow boat.
Hopefully, the Clinical Updates PR will give the push to finally complete enrollment of the 12 adult female Rett patients needed for the trial.
I'm guessing reluctance to enroll has been based on the one-time injection into the intrathecal space (directly into the Cerebral Spinal Fluid).
It's definitely worth the risk, IMO. Good Luck to All.
👍️0

최근 히스토리

NASDAQ
TSHA
Taysha Gene Therapies
LSE
VAGU
Vanglbaggetf
NASDAQ
CBGOX
Ci Alternative Investmen...
COIN
MTCNUSD
ManateeCoin
USOTC
LKFKY
Luk Fook (PK)
NASDAQ
JSMD
Janus Henderson Small Mi...
NASDAQ
CAYWX
Canadian Equity Managed ...
USOTC
FGPRB
Ferrellgas Partners LP U... (PK)
USOTC
LWSGF
Lewis (PK)
NASDAQ
CBMMX
Ci Canadian Asset Alloca...
LSE
HPRD
Hsbc Ftse Ep $
NASDAQ
CBCQX
Canadian Equity Value Po...
NASDAQ
CBRNX
Ci Canadian Bond Corpora...
EU
MTD
Amundi Euro Government B...
NASDAQ
CBRGX
Ci Canadian Banks Covere...
USOTC
BKKPF
Bangkok Bank Public (PK)
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지